Focusing on three major species: human, rat, and mouse to provide cost-effective,
multiplexed detection solutions.
Dedicated support to accelerate your research progress.
CUSABIO has meticulously developed three distinct panels to help you unravel inflammatory status, mechanisms, and balance with exceptional cost-effectiveness, empowering high-quality research.
Broad Species Coverage: Our panels are specifically designed for the three major research species: human, rat, and mouse.
Robust & Reliable Technology: Built on a high-performance ELISA platform, our assays deliver high sensitivity and specificity for dependable results.
Comprehensive Service: We provide end-to-end professional support, from sample testing to data analysis.
Globally Cited & Trusted: Our products are cited in over 27,000 publications, a testament to their reliability and global acceptance by the scientific community.
Three Targeted Panels to Meet the Demands of Your Research CUSABIO enables a seamless progression from foundational insights to deep mechanistic exploration.
Core Entry-Level Choice
Assay Indices: IL-6 + IL-1B + TNF-α
3+1 Mechanism Exploration
Assay Indices: IL-6 + IL-1B + TNF-α + IL-10 or IL-8 (CXCL8)
3+2 Plex Solution for Holistic Insight
Assay Indices: IL-6 + IL-1B + TNF-α + IL-10 + IL-8 (CXCL8)
Target | Product Name | Code | Detection Range | Sensitivity |
---|---|---|---|---|
TNF | Human Tumor necrosis factor α,TNF-α ELISA KIT | CSB-E04740h-IS | 7.8 pg/mL-500 pg/mL | 1.95 pg/mL |
TNF | Human Tumor necrosis factor α,TNF-α ELISA KIT | CSB-E04740h | 7.8 pg/mL-500 pg/mL | 1.95 pg/mL |
IL6 | Human Interleukin 6,IL-6 ELISA KIT | CSB-E04638h | 7.8 pg/mL-500 pg/mL | 2.453 pg/mL |
IL1B | Human Interleukin 1β,IL-1β ELISA Kit | CSB-E08053h-IS | 2.344 pg/ml-150 pg/ml | 0.586 pg/ml |
IL1B | Human Interleukin 1β,IL-1β ELISA Kit | CSB-E08053h | 7.8 pg/ml - 500 pg/ml | 1.95 pg/ml |
IL10 | Human Interleukin 10,IL-10 ELISA Kit | CSB-E04593h-IS | 3.9 pg/ml-250 pg/ml | 0.975 pg/ml |
IL10 | Human Interleukin 10,IL-10 ELISA KIT | CSB-E04593h | 31.25 pg/ml - 2000 pg/ml | 7.8 pg/ml |
CXCL8 | Human Interleukin 8,IL-8 ELISA KIT | CSB-E04641h | 31.25 pg/mL-2000 pg/mL | 7.110 pg/mL |
Target | Product Name | Code | Detection Range | Sensitivity |
---|---|---|---|---|
TNF | Rat TNF-α ELISA kit | CSB-E11987r-IS | 15.6 pg/mL-1000 pg/mL | 3.9 pg/mL |
TNF | Rat TNF-α ELISA kit | CSB-E11987r | 6.25 pg/mL-400 pg/mL | 1.56 pg/mL |
IL6 | Rat Interleukin 6,IL-6 ELISA KIT | CSB-E04640r | 0.312 pg/ml-20 pg/ml | 0.078 pg/ml |
IL1B | Rat Interleukin 1β,IL-1β ELISA Kit | CSB-E08055r-IS | 31.25 pg/mL-2000 pg/mL | 15.6 pg/mL |
IL1B | Rat Interleukin 1β,IL-1β ELISA Kit | CSB-E08055r | 0.156 ng/ml-10 ng/ml. | 0.039 ng/ml. |
IL10 | Rat Interleukin 10,IL-10 ELISA KIT | CSB-E04595r | 3.12 pg/ml-200 pg/ml. | 0.78 pg/ml. |
Target | Product Name | Code | Detection Range | Sensitivity |
---|---|---|---|---|
TNF | Mouse Tumor necrosis factor α,TNF-α ELISA KIT | CSB-E04741m(1) | 62.5 pg/mL-4000 pg/mL | 15.6 pg/mL |
TNF | Mouse Tumor necrosis factor α,TNF-α ELISA Kit | CSB-E04741m-IS | 7.8 pg/ml-500 pg/ml | 1.95 pg/ml |
TNF | Mouse Tumor necrosis factor α,TNF-α ELISA KIT | CSB-E04741m | 15.6 pg/ml-1000 pg/ml | 3.9 pg/ml |
IL6 | Mouse Interleukin 6,IL-6 ELISA Kit | CSB-E04639m-IS | 3.9 pg/ml-250 pg/ml | 0.975 pg/ml |
IL6 | Mouse Interleukin 6,IL-6 ELISA KIT | CSB-E04639m | ||
IL1B | Mouse Interleukin 1β,IL-1β ELISA Kit | CSB-E08054m-IS | 12.5 pg/ml-800 pg/ml | 3.125 pg/ml |
IL1B | Mouse Interleukin 1β (IL-1β) ELISA Kit | CSB-E08054m(1) | 78 pg/ml-5000 pg/ml | 19.5 pg/ml |
IL1B | Mouse Interleukin 1β,IL-1β ELISA Kit | CSB-E08054m | ||
IL10 | Mouse interleukin 10,IL-10 ELISA KIT | CSB-E04594m-IS | 3.12 pg/mL-200 pg/mL | 0.78 pg/mL |
IL10 | Mouse interleukin 10,IL-10 ELISA KIT | CSB-E04594m | 62.5 pg/ml - 4000 pg/ml | 15.6 pg/ml |
The publications below demonstrate the critical role of inflammatory factors, measured using CUSABIO panels, across various disease models.
In this study, inflammatory cytokines (e.g., IFNα, IFNβ, TNFα) served as core biomarkers that validated the mechanism whereby REXO2 mutation activates the MDA5 pathway via mitochondrial RNA leakage, leading to an interferonopathy. Furthermore, these cytokines functioned as key effector molecules driving patient phenotypes (such as cutaneous inflammation and hyper-IgE) and represent potential therapeutic targets (e.g., response to JAK inhibitors).
References: Heterozygous de novo dominant negative mutation of REXO2 results in interferonopathy. Nat Commun, 2024.
Research indicates that pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6) act as pivotal mediators linking high-fat diet-induced gut dysbiosis to ovarian dysfunction. Specifically, following the compromise of intestinal barrier integrity and activation of the ovarian TLR4/NF-κB signaling pathway, these cytokines directly impair ovarian function—independent of metabolic disturbances—by suppressing the expression of estrogen-synthesizing enzymes and exacerbating follicular apoptosis
References: High-fat diet-induced L-saccharopine accumulation inhibits estradiol synthesis and damages oocyte quality by disturbing mitochondrial homeostasis. Gut Microbes, 2024.
In this study, inflammatory cytokines (e.g., IL-6, TNF-α, IL-10, TGF-β) were identified as the key mechanism underlying PS-MPs-induced spermatogenic dysfunction, wherein they mediate an imbalance in the testicular immune microenvironment. This sustained inflammatory response consequently disrupts spermatogonial differentiation, meiosis, and the integrity of the blood-testis barrier.
References: Prenatal and postnatal exposure to polystyrene microplastics induces testis developmental disorder and affects male fertility in mice. J Hazard Mater, 2023.
In the study, inflammatory cytokines (e.g., IL-8, IFN-γ) served a dual role: as key biomarkers reflecting the severity of the cytokine storm in COVID-19 patients, and as core indicators for evaluating the anti-inflammatory efficacy of candidate drugs (felodipine, fasudil, imatinib, caspofungin).
References: A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19. Cell Mol Immunol, 2023.
In radiation-induced lung injury (RILI), key mediators including IL-1β (an effector of the NLRP3 pathway), IL-6, TNF-α (pro-inflammatory factors), and TGF-β1 (a key driver of fibrosis) collectively exacerbate inflammatory infiltration and collagen deposition. ACT001 significantly reduces the levels of these cytokines by inhibiting the NLRP3 inflammasome, thereby alleviating both pulmonary inflammation and the progression of fibrosis.
References: ACT001 Ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway. Biomed Pharmacother, 2023.
The study demonstrated that metformin administered via both routes significantly suppressed the LPS-induced increase in levels of IL-1, IL-6, and TNF-α, with intraperitoneal injection showing a more pronounced reduction in IL-6. However, neither administration method had a significant effect on IL-17 levels. These findings suggest that by inhibiting the pro-inflammatory cytokine storm, metformin may have potential therapeutic value for human diseases driven by elevated cytokine levels.
References: Anti‑inflammatory effect of metformin against an experimental model of LPS‑induced cytokine storm. Exp Ther Med, 2023.